HCPCS Codes Similar to J3402

HCPCS Codes Similar to “J3402” Code.
Injection, remestemcel-l-rknd, per therapeutic dose

C7523 Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	C7525 Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
C7527 Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	A9543 Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries Code added date: 20060101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
A9545 Iodine i-131 tositumomab, therapeutic, per treatment dose Code added date: 20060101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	A9604 Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries Code added date: 20100101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
C1717 Brachytherapy source, non-stranded, high dose rate iridium-192, per source Code added date: 20010401 Code effective date: 20010401 TXT \| PDF \| XML \| JSON	C1719 Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source Code added date: 20010401 Code effective date: 20010401 TXT \| PDF \| XML \| JSON
C9073 Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20210101 Code effective date: 20210401 TXT \| PDF \| XML \| JSON	C9076 Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20210701 Code effective date: 20211001 TXT \| PDF \| XML \| JSON
C9081 Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20211001 Code effective date: 20220101 TXT \| PDF \| XML \| JSON	C9098 Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20220701 Code effective date: 20221001 TXT \| PDF \| XML \| JSON
C9172 Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose Code added date: 20241001 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	C9301 Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20250401 Code effective date: 20250701 TXT \| PDF \| XML \| JSON